caa a22 4500 477062164 CHVBK 20180405111403.0 cr unu---uuuuu 170330e19960601xx s 000 0 eng 10.1007/BF00132409 doi (NATIONALLICENCE)springer-10.1007/BF00132409 Detsky Allan Departments of Health Administration and Medicine, University of Toronto and Division of General Internal Medicine and Clinical Epidemiology Unit, The Toronto Hospital, Toronto, Ontario, Canada aut Costs in perspective: Understanding cost-effectiveness analysis [Elektronische Daten] [Allan Detsky] This paper covers five questions: (1) What is cost-effectiveness analysis? (2) How can cost-effectiveness analysis help policymakers allocate scarce resources? (3) What are misconceptions about the cost effectiveness of health care interventions? (4) What is an attractive cost-effectiveness ratio? (5) What is the relevance of cost effectiveness to clinicians? The cost side of the equation includes more than simply the cost of the intervention, but rather the cost of all of the downstream clinical events that occur with either therapeutic alternative. Cost-effectiveness analyses are used to help decisionmakers rank programs competing for scarce resources in order to achieve the following objective: to maximize the net health benefits derived from a fixed budget for a target population. A simple example is shown. Measured cost-effectiveness ratios for selected cardiovascular interventions are displayed. The systematic use of information on effectiveness and cost effectiveness should help those involved in setting policies to have a more rational basis for funding of new programs and discontinuation of funding for old programs. In Canadian health care it is important that we use this information to make room for innovations that are effective and efficient, and to remove funding from programs that are either known to be ineffective and costly or inefficient use of resources. More energy should be put toward generating the information necessary to make these kinds of decisions. Kluwer Academic Publishers, 1996 cost effectiveness nationallicence analysis nationallicence health policy nationallicence resource allocation nationallicence Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 3/2(1996-06-01), 157-161 0929-5305 3:2<157 1996 3 11239 https://doi.org/10.1007/BF00132409 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00132409 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Detsky Allan Departments of Health Administration and Medicine, University of Toronto and Division of General Internal Medicine and Clinical Epidemiology Unit, The Toronto Hospital, Toronto, Ontario, Canada aut NATIONALLICENCE 773 0- Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 3/2(1996-06-01), 157-161 0929-5305 3:2<157 1996 3 11239 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer